Survival and drug persistence in patients receiving inhaled treprostinil at doses greater than 54 µg (nine breaths) four times daily
Sign Up to like & getrecommendations! Published in 2021 at "Pulmonary Circulation"
DOI: 10.1177/20458940211052228
Abstract: Treprostinil is a prostacyclin approved for the treatment of pulmonary arterial hypertension. Commercial data sets indicate that approximately 20–25% of patients are prescribed a higher dose than the maximum recommended dosage of nine breaths per… read more here.
Keywords: doses bps; bps qid; patients receiving; treprostinil doses ... See more keywords